Igyxos Competitors and Similar CompaniesClear all
Igyxos's competitors and similar companies include Versantis, Wren Therapeutics, Roche and BioArctic.
 Igyxos Igyxos is a biotech startup developing pharmaceuticals and medical technologies in the field of human fertility. |  Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. |  Wren Therapeutics Wren Therapeutics is a biopharmaceutical company, which is focused on drug discovery and development for protein misfolding diseases. |  BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. | ||
Founding Date | Founding Date 2019 | Founding Date 2015 | Founding Date 2016 | Founding Date 1896 | Founding Date 2003 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Nouzilly, FR HQ | Locations Zürich, CH HQ | Locations Cambridge, GB HQ Lund, SE Cambridge, GB Cambridge, US | Locations Stockholm , SE HQ | |
Employees | Employees 15 | Employees 2 | Employees 138% increase | Employees 103,249 | Employees 107 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) kr2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF13.1b (FY, 2025) | Cost of goods kr59.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit CHF50.5b (FY, 2025) | Gross profit kr1.9b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income CHF13.8b (FY, 2025) | Net income kr1b (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 8.5m (about 7 years ago) | Latest funding round $ 16.1m (over 6 years ago) | Latest funding round $ 23.3m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 8.5m | Total funding raised $ 20.7m | Total funding raised $ 23.3m | Total funding raised $ 7.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Versantis
HQ
Zürich, CH
Employees
2
Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications.
View companyWren Therapeutics
HQ
Cambridge, GB
Employees
13↑ 8% increase
Wren Therapeutics is a biopharmaceutical company, which is focused on drug discovery and development for protein misfolding diseases.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyBioArctic
HQ
Stockholm , SE
Employees
107
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View company